MatTek Life Sciences

07/30/2025

MatTek is heading to the World Congress on Alternatives and Animal Use in the Life Sciences!

We will be exhibiting, presenting talks and posters, and hosting a free workshop at the 13th World Congress on Alternatives and Animal Use in the Life Sciences (WC13) this August in Rio de Janeiro. This global event brings together leaders in New Approach Methodologies (NAMs), and we’re proud to be part of the conversation shaping the future of non-animal testing.

📢 Featured Satellite Workshop: “3D Models Applications in Toxicology”
• Explore the science behind human organotypic tissue models
• Learn how these models support regulatory NAMs adoption
• Hands-on training for select participants (space is limited!)

Get all the details and register for our workshop: http://bit.ly/4lTdfQI

MatTek is exhibiting at the World Congress for Animal Alternatives in Rio de Janeiro. Register for our workshop!

07/08/2025

📢 News: MatTek is Now Part of Sartorius 📢

We’re proud to share that Sartorius has officially completed the acquisition of MatTek. This is a major milestone that opens exciting new opportunities for innovation in human-relevant in vitro science.

What stays the same: Our commitment to scientific excellence, customer support, and your trusted points of contact. 🤝

What’s new: A stronger global platform to accelerate the adoption of non-animal testing methods and deliver even more impactful solutions to our partners worldwide. 👏🚀💛

Read the full CEO statement: https://www.mattek.com/ceo-statement-sartorius-completes-acqusition-of-mattek/

05/01/2025

If you missed our poster presentation at the AACR Annual Meeting, we’ve made it easy for you to catch up!

📌 Our poster "Large Scale in vitro Expansion of Primary Tumors from Metastatic Cancer Patients with Different Mutations for Preclinical Drug Screening" is now available for download.

🔽 Download the poster here: https://www.mattek.com/aacr-2025/

04/08/2025

📢 Last chance to register!

Join us tomorrow for an unmissable webinar discussing a project that signals a shift towards NAMs technology by a key stakeholder in traditional testing methods. Learn about the first phase of the project, what comes next, and a discussion on the future of testing landscape.

Register now: https://bit.ly/42pH9nt

03/11/2025

📢 Live Webinar! 📢

Join Charles River Labs and MatTek Life Sciences as they present groundbreaking research on a New Approach Methodology (NAM) for inhalation toxicology testing—helping reduce reliance on traditional animal research. 🔬🐀

This webinar will cover findings from the first phase of the project, future research plans, and the evolving testing landscape. A live Q&A session follows, and all registrants receive the recording.

📅 Wednesday, April 9th
🕤 9:30AM EST

Register now: https://bit.ly/4kGDoC7

09/18/2024

MatTek is exhibiting and presenting this week at the Association of Inhalation Toxicologists Annual Conference. Dr. Seyoum Ayehunie is presenting a poster on the development of multi-species airway tissue models.

One of the challenges in the adoption of NAMs is the existence of large databases of animal toxicity data which are not directly translatable to data obtained from human in vitro airway tissue models due to species differences. To close that translational gap, Dr. Ayehunie and our R&D group have developed airway models from cells harvested from rats and non-human primates (NHP) to compare data to EpiAirway, MatTek's human airway model.

These translational tools are vital to predicting airway inhalation toxicity and for bridging the in vitro-in vivo knowledge gap to reliably predict human responses, while providing an alternative approach to animal experimentation.

Download the poster: https://bit.ly/3TxIbtV

09/16/2024

MatTek scientists presented posters with new research at the Eurotox Congress in Copenhagen, Denmark, last week. Posters include information on the development of our groundbreaking new EpiKidney tissue model, multi-species translational biology, and pre-validation of the EpiDerm model for skin sensitization.

See what we've been working on and download copies of our posters: https://bit.ly/4emYDVK

hashtag hashtag

06/27/2024

MatTek had the pleasure of speaking and exhibiting at the Massachusetts State House in support of H.850 sponsored by Rep. Jack Patrick Lewis and Senator Mark Montigny. The bill would require manufacturers to use effective, non-animal testing methods when available for cosmetics, household cleaners, and industrial chemicals. MatTek produces many types of lab-grown human tissues that accompany test protocols validated by global regulatory agencies, such as the OECD, that are utilized by companies worldwide to ensure the safety and efficacy of their consumer products.

The importance of legislative leadership to encourage the acceptance of NAMs cannot be overstated, and we are proud to support this effort in our home state with science-based solutions produced in Massachusetts labs. Many thanks to The Humane Society of the United States – End Animal Testing Campaign for organizing this event!

06/25/2024

Earlier this month, MatTek's Chief Scientific Officer, Dr. Seyoum Ayehunie, presented a poster on groundbreaking work performed by our R&D team under his leadership. The development of a vascularized, metastatic colorectal cancer model for drug testing can have far reaching impacts from medical research to patient outcomes.

This project is born of our partnership with NEXT Oncology the goal of which is utilizing their inventory of patient-derived cancer cells to replicate cancerous tumors in vitro, so that more effective therapies can be developed by medical and pharmaceutical researchers.

Download the poster: https://bit.ly/3RHfFVQ

06/17/2024

ICYMI: MatTek, in collaboration with Charles River Labs has been awarded a grant from the Foundation for Chemistry Research and Initiatives to advance non-animal research. The program will develop a new approach method (NAM) for inhalation toxicology. As leaders in the field of human tissue engineering, and the creators of EpiAirway, MatTek is uniquely qualified to lend its expertise to the project.

“This partnership marks a pivotal moment where innovation and collaboration will lead us toward safer and more reliable outcomes for all," said MatTek CEO Alex Armento.

Read more: https://bit.ly/3z8QLrK